drugset / Trial / NCT01368419
Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
Phase 2
Unknown
40 enrolled
Jiangsu Simcere Pharmaceutical Co., Ltd.
The First People's Hospital of Lianyungang · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is to explore the clinical efficacy of continuous Endostar infusion combined with radiotherapy in esophageal cancer patients.
Timeline
- Start
- 2011-05
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Endostar | Protein / enzyme biologic | 75 mg | — |